Literature DB >> 9835509

Characterization of a chromosomal gene encoding type B beta-lactamase in phage group II isolates of Staphylococcus aureus.

R K Voladri1, D S Kernodle.   

Abstract

In contrast to most Staphylococcus aureus isolates in which the gene for staphylococcal beta-lactamase (blaZ) is plasmid borne, isolates typeable by group II bacteriophages frequently carry blaZ on the chromosome. Furthermore, the chromosomal gene encodes the type B variant of staphylococcal beta-lactamase for which the nucleotide and deduced amino acid sequences have not yet been reported. To better understand beta-lactamase production among phage group II staphylococci and the nature of the type B beta-lactamase, we determined the type and amount of enzyme produced by 24 phage group II isolates. Of these isolates, 1 did not produce beta-lactamase, 8 produced the type B enzyme, and 15 produced the type C enzyme. In all eight type B beta-lactamase-producing isolates, blaZ was located on the chromosome. This was in contrast to the type C beta-lactamase-producing isolates, in which blaZ was located on a 21-kb plasmid. The nucleotide sequence corresponding to the leader peptide and the N-terminal 85% of the mature exoenzyme form of type B S. aureus was determined. The deduced amino acid sequence revealed 3 residues in the leader peptide and 12 residues in the exoenzyme portion of the beta-lactamase that differ from the prototypic type A beta-lactamase sequence. These include the serine-to-asparagine change at residue 216 found in the kinetically similar type C enzyme, a threonine-to-lysine change at residue 128 close to the SDN loop (residues 130 to 132), and several substitutions not found in any of the other staphylococcal beta-lactamases. In summary, modern isolates of S. aureus typeable by group II phages produce type B or type C staphylococcal beta-lactamase. The type B gene resides on the chromosome and has a sequence that, when compared to the sequences of the other staphylococcal beta-lactamases, corresponds well with its kinetic properties.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9835509      PMCID: PMC106017     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  34 in total

1.  An unusual "penicillinase plasmid" in staphylococcus aureus; evidence for its transfer under natural conditions.

Authors:  R W Lacey; V T Rosdahl
Journal:  J Med Microbiol       Date:  1974-02       Impact factor: 2.472

2.  A spectrophotometric assay of beta-lactamase action on penicillins.

Authors:  S G Waley
Journal:  Biochem J       Date:  1974-06       Impact factor: 3.857

3.  Naturally occurring constitutive -lactamase of novel serotype in Staphylococcus aureus.

Authors:  V T Rosdahl
Journal:  J Gen Microbiol       Date:  1973-07

4.  Comparison of assay techniques for beta-lactamase activity.

Authors:  G W Ross; K V Chanter; A M Harris; S M Kirby; M J Marshall; C H O'Callaghan
Journal:  Anal Biochem       Date:  1973-07       Impact factor: 3.365

5.  The genetics of penicillinase production in Staphylococcus aureus strain PS80.

Authors:  E H Asheshov
Journal:  J Gen Microbiol       Date:  1969-12

6.  Penicillinase production and metal-ion resistance in Staphylococcus aureus cultures isolated from hospital patients.

Authors:  K G Dyke; M T Parker; M H Richmond
Journal:  J Med Microbiol       Date:  1970-02       Impact factor: 2.472

7.  Change of a single amino acid in the leader peptide of a staphylococcal beta-lactamase prevents the appearance of the enzyme in the medium.

Authors:  A K East; S P Curnock; K G Dyke
Journal:  FEMS Microbiol Lett       Date:  1990-06-01       Impact factor: 2.742

8.  Role of the conserved amino acids of the 'SDN' loop (Ser130, Asp131 and Asn132) in a class A beta-lactamase studied by site-directed mutagenesis.

Authors:  F Jacob; B Joris; S Lepage; J Dusart; J M Frère
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

9.  The amino acid sequence of Staphylococcus aureus penicillinase.

Authors:  R P Ambler
Journal:  Biochem J       Date:  1975-11       Impact factor: 3.857

10.  Chromosomal penicillin resistance in Staphylococcus aureus strains of phage group II.

Authors:  J A Meijers; E E Stobberingh
Journal:  Antonie Van Leeuwenhoek       Date:  1980       Impact factor: 2.271

View more
  20 in total

1.  Comparison of tests for detection of beta-lactamase-producing staphylococci.

Authors:  A Pitkälä; L Salmikivi; P Bredbacka; A-L Myllyniemi; M T Koskinen
Journal:  J Clin Microbiol       Date:  2007-04-11       Impact factor: 5.948

2.  Novel Insights into the Classification of Staphylococcal β-Lactamases in Relation to the Cefazolin Inoculum Effect.

Authors:  Lina P Carvajal; Sandra Rincon; Aura M Echeverri; Jessica Porras; Rafael Rios; Karen M Ordoñez; Carlos Seas; Sara I Gomez-Villegas; Lorena Diaz; Cesar A Arias; Jinnethe Reyes
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

3.  Cefazolin Inoculum Effect and Methicillin-Susceptible Staphylococcus aureus Osteoarticular Infections in Children.

Authors:  J Chase McNeil; Lauren M Sommer; Mary Boyle; Patrick Hogan; Jesus G Vallejo; Kristina G Hultén; Anthony R Flores; Sheldon L Kaplan; Stephanie Fritz
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

4.  Real-time PCR assay for detection of blaZ genes in Staphylococcus aureus clinical isolates.

Authors:  Lynette A Pereira; Gerald B Harnett; Meredith M Hodge; Julia A Cattell; David J Speers
Journal:  J Clin Microbiol       Date:  2014-01-29       Impact factor: 5.948

5.  Determination of an inoculum effect with various cephalosporins among clinical isolates of methicillin-susceptible Staphylococcus aureus.

Authors:  Esteban C Nannini; Martin E Stryjewski; Kavindra V Singh; Tom H Rude; G Ralph Corey; Vance G Fowler; Barbara E Murray
Journal:  Antimicrob Agents Chemother       Date:  2010-03-08       Impact factor: 5.191

6.  Efficacy of Ceftaroline against Methicillin-Susceptible Staphylococcus aureus Exhibiting the Cefazolin High-Inoculum Effect in a Rat Model of Endocarditis.

Authors:  Kavindra V Singh; Truc T Tran; Esteban C Nannini; Vincent H Tam; Cesar A Arias; Barbara E Murray
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

7.  Identification of a β-lactamase inhibitory protein variant that is a potent inhibitor of Staphylococcus PC1 β-lactamase.

Authors:  Ji Yuan; Dar-Chone Chow; Wanzhi Huang; Timothy Palzkill
Journal:  J Mol Biol       Date:  2011-01-13       Impact factor: 5.469

8.  Association between Type A blaZ Gene Polymorphism and Cefazolin Inoculum Effect in Methicillin-Susceptible Staphylococcus aureus.

Authors:  Sun Hee Lee; Wan Beom Park; Shinwon Lee; Sohee Park; Shin Woo Kim; Jong-Myung Lee; Hyun Ha Chang; Ki Tae Kwon; Pyoeng Gyun Choe; Nam Joong Kim; Hong Bin Kim; Myoung-Don Oh
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

9.  Staphylococcus aureus extracellular vesicles carry biologically active β-lactamase.

Authors:  Jaewook Lee; Eun-Young Lee; Si-Hyun Kim; Dae-Kyum Kim; Kyong-Su Park; Kwang Pyo Kim; Yoon-Keun Kim; Tae-Young Roh; Yong Song Gho
Journal:  Antimicrob Agents Chemother       Date:  2013-03-25       Impact factor: 5.191

10.  Phage typing, PCR amplification for mecA gene, and antibiotic resistance patterns as epidemiologic markers in nosocomial outbreaks of methicillin resistant Staphylococcus aureus.

Authors:  M Al-Khulaifi Manal; M Amin Aref Nagwa; Ali A Al Salamah
Journal:  Saudi J Biol Sci       Date:  2009-07       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.